新西兰向医生支付药品费用的披露计划排除了非新西兰药品协会成员，并省略了某些支付类型。 New Zealand's disclosure scheme for pharmaceutical payments to doctors excludes non-Medicines New Zealand members and omits certain payment types.
新西兰向医生支付药品费用的新披露计划被认为没有达到最佳实践。 New Zealand's new disclosure scheme for pharmaceutical payments to doctors has been deemed to fall short of best practice. 尽管由于缺乏相关立法，该计划的发展值得欢迎，但该计划仅包括新西兰药品协会的成员，仅占在该国运营的制药公司的一半以下。 Though a welcome development given the absence of relevant legislation, the scheme only includes members of Medicines New Zealand, representing less than half the pharmaceutical companies operating in the country. 一些会员公司没有参与，并且省略了几种付款方式，包括招待费、会议赞助费和研究经费。 Some member companies did not participate and several payment types, including hospitality, conference sponsorship, and research funding, were omitted.